Anti-TGFB2重组抗体|科研级 Lerdelimumab ( 乐德木单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-TGFB2重组抗体|科研级 Lerdelimumab ( 乐德木单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-TGFB2重组抗体|科研级 Lerdelimumab ( 乐德木单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1117

Alias

科研级 Lerdelimumab ( 乐德木单抗 ), Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab

Molecular Name

Lerdelimumab

Size

1mg, 5mg

CAS Number

285985-06-0

Isotype

IgG4

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

TGFB2[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Lerdelimumab (CAT-152, intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug targeting TGF beta 2. It was being developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results for that condition.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ